JP2022547692A5 - - Google Patents
Info
- Publication number
- JP2022547692A5 JP2022547692A5 JP2022516034A JP2022516034A JP2022547692A5 JP 2022547692 A5 JP2022547692 A5 JP 2022547692A5 JP 2022516034 A JP2022516034 A JP 2022516034A JP 2022516034 A JP2022516034 A JP 2022516034A JP 2022547692 A5 JP2022547692 A5 JP 2022547692A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- pharmaceutical composition
- composition according
- fusion
- polypeptides
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025084545A JP2025124714A (ja) | 2019-09-13 | 2025-05-21 | 免疫複合体介在性腎臓障害の処置のための組み換えＩｇＧ Ｆｃ多量体 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19197287.6 | 2019-09-13 | ||
| EP19197287 | 2019-09-13 | ||
| PCT/EP2020/075432 WO2021048330A1 (en) | 2019-09-13 | 2020-09-11 | Recombinant igg fc multimers for the treatment of immune complex-mediated kidney disorders |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025084545A Division JP2025124714A (ja) | 2019-09-13 | 2025-05-21 | 免疫複合体介在性腎臓障害の処置のための組み換えＩｇＧ Ｆｃ多量体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022547692A JP2022547692A (ja) | 2022-11-15 |
| JP2022547692A5 true JP2022547692A5 (https=) | 2023-09-19 |
| JP7734652B2 JP7734652B2 (ja) | 2025-09-05 |
Family
ID=68084577
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022516034A Active JP7734652B2 (ja) | 2019-09-13 | 2020-09-11 | 免疫複合体介在性腎臓障害の処置のための組み換えＩｇＧ Ｆｃ多量体 |
| JP2025084545A Pending JP2025124714A (ja) | 2019-09-13 | 2025-05-21 | 免疫複合体介在性腎臓障害の処置のための組み換えＩｇＧ Ｆｃ多量体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025084545A Pending JP2025124714A (ja) | 2019-09-13 | 2025-05-21 | 免疫複合体介在性腎臓障害の処置のための組み換えＩｇＧ Ｆｃ多量体 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20220332847A1 (https=) |
| EP (1) | EP4028415A1 (https=) |
| JP (2) | JP7734652B2 (https=) |
| KR (1) | KR20220062084A (https=) |
| CN (1) | CN114401985A (https=) |
| AU (1) | AU2020344164A1 (https=) |
| BR (1) | BR112022003713A2 (https=) |
| CA (1) | CA3150680A1 (https=) |
| WO (1) | WO2021048330A1 (https=) |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5677425A (en) | 1987-09-04 | 1997-10-14 | Celltech Therapeutics Limited | Recombinant antibody |
| GB9625640D0 (en) | 1996-12-10 | 1997-01-29 | Celltech Therapeutics Ltd | Biological products |
| GB9720054D0 (en) | 1997-09-19 | 1997-11-19 | Celltech Therapeutics Ltd | Biological products |
| ES2551439T5 (es) | 2003-07-01 | 2018-11-08 | Ucb Biopharma Sprl | Fragmentos Fab de anticuerpos modificados |
| GB0315457D0 (en) | 2003-07-01 | 2003-08-06 | Celltech R&D Ltd | Biological products |
| GB0315450D0 (en) | 2003-07-01 | 2003-08-06 | Celltech R&D Ltd | Biological products |
| AU2005285347A1 (en) * | 2004-08-19 | 2006-03-23 | Genentech, Inc. | Polypeptide variants with altered effector function |
| PL2185589T3 (pl) | 2007-06-01 | 2016-09-30 | Środki wiążące receptor regionu stałego Fc immunoglobuliny | |
| TWI542597B (zh) | 2010-07-28 | 2016-07-21 | 吉林尼克公司 | 產生依序多聚體化免疫球蛋白ｆｃ組合物之天然人類蛋白質片段之融合蛋白 |
| WO2013112986A1 (en) | 2012-01-27 | 2013-08-01 | Gliknik Inc. | Fusion proteins comprising igg2 hinge domains |
| BR112015008663B1 (pt) | 2012-10-17 | 2021-01-12 | CSL Behring Lengnau AG | Uso de uma quantidade eficaz de uma proteína polimérica compreendendo seis unidades demonômero de polipeptídeo |
| CA2939201A1 (en) | 2014-03-05 | 2015-09-11 | Ucb Biopharma Sprl | Multimeric fc proteins |
| MX2016010951A (es) | 2014-03-05 | 2016-11-29 | Ucb Biopharma Sprl | Proteinas de fc multimericas. |
| EP4299595A3 (en) | 2014-05-02 | 2024-03-13 | Momenta Pharmaceuticals, Inc. | Compositions and methods related to engineered fc constructs |
| KR20250053203A (ko) | 2015-07-24 | 2025-04-21 | 글리크닉 인코포레이티드 | 향상된 상보체 결합을 갖는 규칙적으로 다형체화된 면역글로불린 fc 조성물을 생성하기 위한 인간 단백질 단편의 융합 단백질 |
| AU2017213117A1 (en) | 2016-01-27 | 2018-07-19 | CSL Behring Lengnau AG | Recombinant IgG Fc multimers |
| AU2017245143B2 (en) | 2016-03-30 | 2024-01-11 | Ab Biosciences, Inc. | Recombinant intravenous immunoglobulin (rIVIG) compositions and methods for their production and use |
| DK3484514T3 (da) | 2016-05-23 | 2024-01-29 | Momenta Pharmaceuticals Inc | Compositions and methods related to engineered fc constructs |
| AU2017279538A1 (en) | 2016-06-07 | 2019-01-03 | Gliknik Inc. | Cysteine-optimized stradomers |
| JP7146771B2 (ja) | 2017-01-06 | 2022-10-04 | モメンタ ファーマシューティカルズ インコーポレイテッド | 操作されたＦｃコンストラクトに関する組成物及び方法 |
| US20210095006A1 (en) * | 2017-12-14 | 2021-04-01 | CSL Behring Lengnau AG | RECOMBINANT IgG Fc MULTIMERS FOR THE TREATMENT OF NEUROMYELITIS OPTICA |
-
2020
- 2020-09-11 AU AU2020344164A patent/AU2020344164A1/en active Pending
- 2020-09-11 CA CA3150680A patent/CA3150680A1/en active Pending
- 2020-09-11 BR BR112022003713A patent/BR112022003713A2/pt unknown
- 2020-09-11 JP JP2022516034A patent/JP7734652B2/ja active Active
- 2020-09-11 WO PCT/EP2020/075432 patent/WO2021048330A1/en not_active Ceased
- 2020-09-11 EP EP20775586.9A patent/EP4028415A1/en active Pending
- 2020-09-11 US US17/641,520 patent/US20220332847A1/en active Pending
- 2020-09-11 KR KR1020227012198A patent/KR20220062084A/ko active Pending
- 2020-09-11 CN CN202080063811.XA patent/CN114401985A/zh active Pending
-
2025
- 2025-05-21 JP JP2025084545A patent/JP2025124714A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20230220081A1 (en) | BISPECIFIC HETERODIMERIC FUSION PROTEINS CONTAINING IL-15 - IL-15Ralpha Fc-FUSION PROTEINS AND IMMUNE CHECKPOINT ANTIBODY FRAGMENTS | |
| US12139525B2 (en) | Targeted heterodimeric Fc fusion proteins containing IL-15 IL-15alpha and antigen binding domains | |
| CN109789203B (zh) | 与经改造的Fc构建体相关的组合物和方法 | |
| JP2022523524A5 (https=) | ||
| KR102247704B1 (ko) | 항 pd-1/항 her2 천연항체 구조 형태의 헤테로다이머 계의 이중특이성 항체 및 그 제조방법 | |
| RU2016139022A (ru) | МУЛЬТИМЕРНЫЕ Fc-БЕЛКИ | |
| JP2018504092A5 (https=) | ||
| IL269395B2 (en) | Immunoconjugation of anti-PD-1 antibody with IL-2 or IL-15 mutation | |
| JP2020511949A5 (https=) | ||
| AU2018277301B2 (en) | Heterodimerizing Ig domains | |
| CN102665759B (zh) | 人源化抗il-22ra抗体 | |
| CA3199447A1 (en) | Fusions with cd8 antigen binding molecules for modulating immune cell function | |
| CN107001468A (zh) | Cd3结合结构域 | |
| JP2015530983A5 (https=) | ||
| WO2022125712A1 (en) | Fusions of mutant interleukin-10 polypeptides with antigen binding molecules for modulating immune cell function | |
| WO2020154540A1 (en) | Anti-cd38 antibodies | |
| JP2022547692A5 (https=) | ||
| JP2023550191A5 (https=) | ||
| US20260098090A1 (en) | Fusions with cd8 antigen binding molecules for treating chronic viral infection | |
| JP2025124714A5 (https=) | ||
| CN119546343A (zh) | 细胞因子融合蛋白与cd8抗原结合分子的组合 | |
| US20250276070A1 (en) | Optimized multabody constructs, compositions, and methods | |
| RU2021121116A (ru) | Новые слитые белки, специфические в отношении cd137 и gpc3 | |
| CN118019767A (zh) | 优化的multabody构建体、组合物和方法 | |
| RU2020139055A (ru) | Новый слитый белок, специфичный для cd137 и pd-l1 |